---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-028003"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2025-12-16T23:59:59+00:00"
generated_at: "2026-05-16T13:04:36.692413+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Nasdaq deficiency letter for bid price non-compliance; 1-for-10 reverse stock split effected

## Summary
- Received Nasdaq deficiency letter on Dec 15 for closing bid price below $1 for 30 consecutive business days.
- Initial compliance period runs through June 15, 2026; cure if bid price ≥ $1 for 10 consecutive days.
- Filed and effected a 1-for-10 reverse stock split on Dec 15; split-adjusted trading began Dec 16.
- If non-compliant by June 15, may qualify for an additional 180-day period if meeting other listing standards.

## SEC filing metadata
- accession: 0001493152-25-028003
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2025-12-16T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000149315225028003/0001493152-25-028003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000149315225028003/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-028003
- JSON: https://secwatch.observer/filing/0001493152-25-028003.json
- Plain text: https://secwatch.observer/filing/0001493152-25-028003.txt

## Source-grounded claims
- claim_id: e44285c22deecfcc34c3774c2ef298bbcbeff5d4
  claim: INTELLIGENT BIO SOLUTIONS INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  evidence_excerpt: December 15, 2025, Intelligent Bio Solutions Inc. (the “Company”) received a deficiency letter from the Nasdaq Listing Qualifications Department (the “Staff”) notifying the Company that because the closing bid price for the Company’s common stock was below $1.00 per share for the last 30 consecutive business days, the Company did not meet the $1.00 per share minimum bid price requirement for continued inclusion on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). The deficiency letter does not result in the immediate delisting of the Company’s common
  evidence_url: https://www.sec.gov/Archives/edgar/data/1725430/000149315225028003/0001493152-25-028003-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.